Josh Muntner is a seasoned biopharmaceutical finance executive with over 25 years of experience as a Chief Financial Officer and investment banker. He has led more than 90 financings and strategic transactions, raising over $9 billion in capital. Mr. Muntner has held senior leadership roles across private and public life sciences companies, with responsibility for global finance, investor relations, and capital markets strategy. He holds a MBA from UCLA Anderson School of Management and a BFA from Carnegie Mellon University.
